Skip to main content
Premium Trial:

Request an Annual Quote

Bit More Diverse, But More to Do

Cancer clinical trials have become more diverse, though some populations are still underrepresented, US News & World Report says.

A University of California, San Diego-led team of researchers examined the representation of minorities, women, and the elderly in clinical trials funded by the US National Cancer Institute. By delving through the NCI Clinical Data Update System, the researchers examined the demographics of 242,720 participants in clinical trials of breast, colorectal, lung, and prostate cancer between 2000 and 2019. As they report in the journal Cancer, they found Black patients were more likely to participate in breast, lung, and prostate cancer trials and Hispanic patients were more likely to participate in breast, colorectal, lung, and prostate cancer trials in 2015 through 2019, as compared to 2000 to 2004.

However, the researchers note that Black and Hispanic patients remain underrepresented in trials. "Our article indicates that the disparity for clinical enrollment in NCI clinical trials has narrowed for minorities, but further efforts are still needed," first author Juan Javier-DesLoges from UC San Diego Health says in a statement.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.